Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 4
2017 34
2018 105
2019 152
2020 161
2021 143
2022 139
2023 101
2024 86

Text availability

Article attribute

Article type

Publication date

Search Results

797 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer.
Sandhya L, Devi Sreenivasan N, Goenka L, Dubashi B, Kayal S, Solaiappan M, Govindarajalou R, Kt H, Ganesan P. Sandhya L, et al. J Clin Oncol. 2023 May 10;41(14):2617-2627. doi: 10.1200/JCO.22.01997. Epub 2023 Mar 28. J Clin Oncol. 2023. PMID: 36977285 Clinical Trial.
The pharmacogenetics of treatment with olanzapine.
Zubiaur P, Soria-Chacartegui P, Villapalos-García G, Gordillo-Perdomo JJ, Abad-Santos F. Zubiaur P, et al. Pharmacogenomics. 2021 Sep;22(14):939-958. doi: 10.2217/pgs-2021-0051. Epub 2021 Sep 16. Pharmacogenomics. 2021. PMID: 34528455
Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T, Hoshina Y, Sakata Y, Takahashi TY, Nakashima K, Nakao M, Takei D, Zenda S, Mizukami K, Iwasa S, Sakurai M, Yamamoto N, Ohe Y. Hashimoto H, et al. Lancet Oncol. 2020 Feb;21(2):242-249. doi: 10.1016/S1470-2045(19)30678-3. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838011 Clinical Trial.
Psychopharmacologic Management of Eating Disorders.
Muratore AF, Attia E. Muratore AF, et al. Curr Psychiatry Rep. 2022 Jul;24(7):345-351. doi: 10.1007/s11920-022-01340-5. Epub 2022 May 16. Curr Psychiatry Rep. 2022. PMID: 35576089 Free PMC article. Review.
Delirium in the Neonate.
Adams SJ, Sprecher A. Adams SJ, et al. Clin Perinatol. 2022 Mar;49(1):1-14. doi: 10.1016/j.clp.2021.11.001. Epub 2022 Jan 21. Clin Perinatol. 2022. PMID: 35209993 Review.
Olanzapine-Induced Bradycardia.
Sachdeva V, Ashraf S, Inam S, Shah K, Singla A, Mansuri Z, Jain B. Sachdeva V, et al. Prim Care Companion CNS Disord. 2023 Aug 15;25(4):22cr03453. doi: 10.4088/PCC.22cr03453. Prim Care Companion CNS Disord. 2023. PMID: 37595163 Free article. No abstract available.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
Yatham LN, Chakrabarty T, Bond DJ, Schaffer A, Beaulieu S, Parikh SV, McIntyre RS, Milev RV, Alda M, Vazquez G, Ravindran AV, Frey BN, Sharma V, Goldstein BI, Rej S, O'Donovan C, Tourjman V, Kozicky JM, Kauer-Sant'Anna M, Malhi G, Suppes T, Vieta E, Kapczinski F, Kanba S, Lam RW, Kennedy SH, Calabrese J, Berk M, Post R. Yatham LN, et al. Bipolar Disord. 2021 Dec;23(8):767-788. doi: 10.1111/bdi.13135. Epub 2021 Nov 1. Bipolar Disord. 2021. PMID: 34599629 Review.
797 results